{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T03:47:48Z","timestamp":1789012068506,"version":"build-2803163510"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,5,6]],"date-time":"2020-05-06T00:00:00Z","timestamp":1588723200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,5,6]],"date-time":"2020-05-06T00:00:00Z","timestamp":1588723200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["UG1CA189823"],"award-info":[{"award-number":["UG1CA189823"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["UG1CA232760"],"award-info":[{"award-number":["UG1CA232760"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["U24CA196171"],"award-info":[{"award-number":["U24CA196171"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["UG1CA189858"],"award-info":[{"award-number":["UG1CA189858"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["UG1CA189997"],"award-info":[{"award-number":["UG1CA189997"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["U10CA180820"],"award-info":[{"award-number":["U10CA180820"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["UG1CA189861"],"award-info":[{"award-number":["UG1CA189861"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["U10CA180868"],"award-info":[{"award-number":["U10CA180868"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1007\/s00520-020-05473-2","type":"journal-article","created":{"date-parts":[[2020,5,6]],"date-time":"2020-05-06T00:02:36Z","timestamp":1588723356000},"page":"387-396","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["A randomized, double-blind, placebo-controlled trial of testosterone for treatment of postmenopausal women with aromatase inhibitor-induced arthralgias: Alliance study A221102"],"prefix":"10.1007","volume":"29","author":[{"given":"Elizabeth","family":"Cathcart-Rake","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Novotny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Leon-Ferre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Le-Rademacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth M.","family":"Storrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Araba A.","family":"Adjei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelby","family":"Terstriep","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Glaser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armando","family":"Giuliano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William R.","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seth","family":"Page","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colleen","family":"Austin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard L.","family":"Deming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret A.","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline M.","family":"Lafky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen N.","family":"Birrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles L.","family":"Loprinzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,6]]},"reference":[{"issue":"9324","key":"5473_CR1","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1016\/S0140-6736(02)09088-8","volume":"359","author":"M Baum","year":"2002","unstructured":"Baum M, Budzar AU, Cuzick J, Forbes J, Houghton JH, Klijn JG, Sahmoud T, ATAC Trialists\u2019 Group (2002) Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial. Lancet 359(9324):2131\u20132139","journal-title":"Lancet"},{"issue":"9453","key":"5473_CR2","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/S0140-6736(04)17666-6","volume":"365","author":"A Howell","year":"2005","unstructured":"Howell A, Cuzick J, Baum M, Buzdar A, Dowsett M, Forbes JF, Hoctin-Boes G, Houghton J, Locker GY, Tobias JS, ATAC Trialists\u2019 Group (2005) Results of the ATAC (Arimidex, tamoxifen, alone or in combination) trial after completion of 5 years\u2019 adjuvant treatment for breast cancer. Lancet 365(9453):60\u201362","journal-title":"Lancet"},{"issue":"6","key":"5473_CR3","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/S0885-3924(02)00395-0","volume":"23","author":"PF Harris","year":"2002","unstructured":"Harris PF, Remington PL, Trentham-Dietz A, Allen CI, Newcomb PA (2002) Prevalence and treatment of menopausal symptoms among breast cancer survivors. J Pain Symptom Manag 23(6):501\u2013509","journal-title":"J Pain Symptom Manag"},{"issue":"1","key":"5473_CR4","doi-asserted-by":"publisher","first-page":"81","DOI":"10.3747\/co.v17i1.473","volume":"17","author":"L Kligman","year":"2010","unstructured":"Kligman L, Younus J (2010) Management of hot flashes in women with breast cancer. Curr Oncol 17(1):81\u201386","journal-title":"Curr Oncol"},{"issue":"25","key":"5473_CR5","doi-asserted-by":"publisher","first-page":"3877","DOI":"10.1200\/JCO.2007.10.7573","volume":"25","author":"KD Crew","year":"2007","unstructured":"Crew KD, Greenlee H, Capodice J, Raptis G, Brafman L, Fuentes D, Sierra A, Hershman DL (2007) Prevalence of joint symptoms in postmenopausal women taking aromatase inhibitors for early-stage breast cancer. J Clin Oncol 25(25):3877\u20133883","journal-title":"J Clin Oncol"},{"issue":"2","key":"5473_CR6","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s10549-007-9774-6","volume":"111","author":"NL Henry","year":"2008","unstructured":"Henry NL, Giles JT, Ang D, Mohan M, Dadabhoy D, Robarge J, Hayden J, Lemler S, Shahverdi K, Powers P, Li L, Flockhart D, Stearns V, Hayes DF, Storniolo AM, Clauw DJ (2008) Prospective characterization of musculoskeletal symptoms in early stage breast cancer patients treated with aromatase inhibitors. Breast Cancer Res Treat 111(2):365\u2013372","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"5473_CR7","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1007\/s10549-013-2504-3","volume":"138","author":"NL Henry","year":"2013","unstructured":"Henry NL, Skaar TC, Dantzer J, Li L, Kidwell K, Gersch C, Nguyen AT, Rae JM, Desta Z, Oesterreich S, Philips S, Carpenter JS, Storniolo AM, Stearns V, Hayes DF, Flockhart DA (2013) Genetic associations with toxicity-related discontinuation of aromatase inhibitor therapy for breast cancer. Breast Cancer Res Treat 138(3):807\u2013816","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"5473_CR8","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1111\/bcp.13130","volume":"83","author":"G Gervasini","year":"2017","unstructured":"Gervasini G, Jara C, Olier C, Romero N, Mart\u00ednez R, Carrillo JA (2017) Polymorphisms in ABCB1 and CYP19A1 genes affect anastrozole plasma concentrations and clinical outcomes in postmenopausal breast cancer patients. Br J Clin Pharmacol 83(3):562\u2013571","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"5473_CR9","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1007\/s10549-015-3634-6","volume":"154","author":"B Leyland-Jones","year":"2015","unstructured":"Leyland-Jones B et al (2015) ESR1 and ESR2 polymorphisms in the BIG 1-98 trial comparing adjuvant letrozole versus tamoxifen or their sequence for early breast cancer. Breast Cancer Res Treat 154(3):543\u2013555","journal-title":"Breast Cancer Res Treat"},{"issue":"31","key":"5473_CR10","doi-asserted-by":"publisher","first-page":"4674","DOI":"10.1200\/JCO.2010.28.5064","volume":"28","author":"JN Ingle","year":"2010","unstructured":"Ingle JN, Schaid DJ, Goss PE, Liu M, Mushiroda T, Chapman JAW, Kubo M, Jenkins GD, Batzler A, Shepherd L, Pater J, Wang L, Ellis MJ, Stearns V, Rohrer DC, Goetz MP, Pritchard KI, Flockhart DA, Nakamura Y, Weinshilboum RM (2010) Genome-wide associations and functional genomic studies of musculoskeletal adverse events in women receiving aromatase inhibitors. J Clin Oncol 28(31):4674\u20134682","journal-title":"J Clin Oncol"},{"issue":"7","key":"5473_CR11","doi-asserted-by":"publisher","first-page":"e0133964","DOI":"10.1371\/journal.pone.0133964","volume":"10","author":"J Wang","year":"2015","unstructured":"Wang J, Lu K, Song Y, Zhao S, Ma W, Xuan Q, Tang D, Zhao H, Liu L, Zhang Q (2015) RANKL and OPG polymorphisms are associated with aromatase inhibitor-related musculoskeletal adverse events in Chinese Han breast cancer patients. PLoS One 10(7):e0133964","journal-title":"PLoS One"},{"issue":"9 Suppl 1","key":"5473_CR12","doi-asserted-by":"publisher","first-page":"S52","DOI":"10.1016\/j.amjmed.2006.07.007","volume":"119","author":"CJ Crandall","year":"2006","unstructured":"Crandall CJ, Crawford SL, Gold EB (2006) Vasomotor symptom prevalence is associated with polymorphisms in sex steroid-metabolizing enzymes and receptors. Am J Med 119(9 Suppl 1):S52\u2013S60","journal-title":"Am J Med"},{"issue":"3","key":"5473_CR13","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s10549-014-2873-2","volume":"144","author":"DYB Fontein","year":"2014","unstructured":"Fontein DYB, Houtsma D, Nortier JW (2014) Germline variants in the CYP19A1 gene are related to specific adverse events in aromatase inhibitor users: a substudy of Dutch patients in the TEAM trial. Breast Cancer Res Treat 144(3):599\u2013606","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"5473_CR14","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s13058-016-0771-8","volume":"18","author":"H Johansson","year":"2016","unstructured":"Johansson H, Gray KP, Pagani O (2016) Impact of CYP19A1 and ESR1 variants on early-onset side effects during combined endocrine therapy in the TEXT trial. Breast Cancer Res 18(1):110","journal-title":"Breast Cancer Res"},{"key":"5473_CR15","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1097\/GME.0000000000000763","volume":"24","author":"C Crandall","year":"2017","unstructured":"Crandall C et al (2017) Association of genetic variation in the tachykinin receptor 3 locus with hot flashes and night sweats in the women\u2019s health initiative study. Menopause 24:252\u2013261","journal-title":"Menopause"},{"issue":"35","key":"5473_CR16","doi-asserted-by":"publisher","first-page":"5147","DOI":"10.1200\/JCO.2010.29.9230","volume":"28","author":"L Bordeleau","year":"2010","unstructured":"Bordeleau L, Pritchard KI, Loprinzi CL, Ennis M, Jugovic O, Warr D, Haq R, Goodwin PJ (2010) Multicenter, randomized, cross-over clinical trial of venlafaxine versus gabapentin for the management of hot flashes in breast cancer survivors. J Clin Oncol 28(35):5147\u20135152","journal-title":"J Clin Oncol"},{"issue":"10","key":"5473_CR17","doi-asserted-by":"publisher","first-page":"3194","DOI":"10.1002\/art.22138","volume":"54","author":"DJ Cirillo","year":"2006","unstructured":"Cirillo DJ, Wallace RB, Wu LL, Yood RA (2006) Effect of hormone therapy on risk of hip and knee joint replacement in the Women\u2019s Health Initiative. Arthritis Rheum 54(10):3194\u20133204","journal-title":"Arthritis Rheum"},{"issue":"3","key":"5473_CR18","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1097\/00006842-196505000-00009","volume":"27","author":"BL Neugarten","year":"1965","unstructured":"Neugarten BL, Kraines RJ (1965) \u201cMenopausal symptoms\u201d in women of various ages. Psychosom Med 27(3):266\u2013273","journal-title":"Psychosom Med"},{"issue":"7","key":"5473_CR19","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.jsgi.2006.07.002","volume":"13","author":"W Dietrich","year":"2006","unstructured":"Dietrich W, Haitel A, Holzer G, Huber JC, Kolbus A, Tschugguel W (2006) Estrogen receptor-\u03b2 is the predominant estrogen receptor subtype in normal human synovia. J Soc Gynecol Investig 13(7):512\u2013517","journal-title":"J Soc Gynecol Investig"},{"issue":"1","key":"5473_CR20","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S0006-8993(97)00092-9","volume":"757","author":"M Dawson-Basoa","year":"1997","unstructured":"Dawson-Basoa M, Gintzler AR (1997) Involvement of spinal cord delta opiate receptors in the antinociception of gestation and its hormonal simulation. Brain Res 757(1):37\u201342","journal-title":"Brain Res"},{"issue":"5","key":"5473_CR21","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.joca.2008.01.002","volume":"16","author":"Y Sniekers","year":"2008","unstructured":"Sniekers Y et al (2008) Animal models for osteoarthritis: the effect of ovariectomy and estrogen treatment\u2013a systematic approach. Osteoarthr Cartil 16(5):533\u2013541","journal-title":"Osteoarthr Cartil"},{"issue":"8","key":"5473_CR22","doi-asserted-by":"publisher","first-page":"2441","DOI":"10.1002\/art.22009","volume":"54","author":"S Oestergaard","year":"2006","unstructured":"Oestergaard S, Sondergaard BC, Hoegh-Andersen P, Henriksen K, Qvist P, Christiansen C, Tank\u00f3 LB, Karsdal MA (2006) Effects of ovariectomy and estrogen therapy on type II collagen degradation and structural integrity of articular cartilage in rats: implications of the time of initiation. Arthritis Rheum 54(8):2441\u20132451","journal-title":"Arthritis Rheum"},{"key":"5473_CR23","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1196\/annals.1351.021","volume":"1069","author":"M Schmidt","year":"2006","unstructured":"Schmidt M et al (2006) Inflammation and sex hormone metabolism. Ann N Y Acad Sci 1069:236\u2013246","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"5473_CR24","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.mce.2010.05.018","volume":"335","author":"U Islander","year":"2011","unstructured":"Islander U, Jochems C, Lagerquist MK, Forsblad-d\u2019Elia H, Carlsten H (2011) Estrogens in rheumatoid arthritis; the immune system and bone. Mol Cell Endocrinol 335(1):14\u201329","journal-title":"Mol Cell Endocrinol"},{"issue":"3","key":"5473_CR25","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.autrev.2003.08.003","volume":"3","author":"M Cutolo","year":"2004","unstructured":"Cutolo M, Villaggio B, Seriolo B, Montagna P, Capellino S, Straub RH, Sulli A (2004) Synovial fluid estrogens in rheumatoid arthritis. Autoimmun Rev 3(3):193\u2013198","journal-title":"Autoimmun Rev"},{"issue":"1","key":"5473_CR26","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1196\/annals.1351.037","volume":"1069","author":"M Cutolo","year":"2006","unstructured":"Cutolo M et al (2006) Anti-TNF and sex hormones. Ann N Y Acad Sci 1069(1):391\u2013400","journal-title":"Ann N Y Acad Sci"},{"issue":"2","key":"5473_CR27","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/s10549-011-1611-2","volume":"130","author":"L Gallicchio","year":"2011","unstructured":"Gallicchio L, MacDonald R, Wood B, Rushovich E, Helzlsouer KJ (2011) Androgens and musculoskeletal symptoms among breast cancer patients on aromatase inhibitor therapy. Breast Cancer Res Treat 130(2):569\u2013577","journal-title":"Breast Cancer Res Treat"},{"key":"5473_CR28","doi-asserted-by":"crossref","unstructured":"Birrell S, Tilley W (2009) Testosterone undecanoate treatment reduces joint morbidities induced by anastrozole tin postmenopausal women with breast cancer: results of a double-blind, randomized phase II trial. AACR","DOI":"10.1158\/0008-5472.SABCS-09-804"},{"key":"5473_CR29","unstructured":"Glaser RL Subcutaneous testosterone-anastrozole implant therapy in breast cancer survivors. ASCO Breast Cancer Conference September 2010: p Abstract # 221"},{"issue":"6","key":"5473_CR30","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/S0885-3924(01)00353-0","volume":"22","author":"JS Carpenter","year":"2001","unstructured":"Carpenter JS (2001) The hot flash related daily interference scale: a tool for assessing the impact of hot flashes on quality of life following breast cancer. J Pain Symptom Manag 22(6):979\u2013989","journal-title":"J Pain Symptom Manag"},{"issue":"1","key":"5473_CR31","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s13058-015-0599-7","volume":"17","author":"J Bauml","year":"2015","unstructured":"Bauml J, Chen L, Chen J, Boyer J, Kalos M, Li SQ, DeMichele A, Mao JJ (2015) Arthralgia among women taking aromatase inhibitors: is there a shared inflammatory mechanism with co-morbid fatigue and insomnia? Breast Cancer Res 17(1):89","journal-title":"Breast Cancer Res"},{"key":"5473_CR32","unstructured":"Biehl B, Landauer A (1975) Das Profile of Mood States (POMS). Mannheim (Unver\u00f6ffentlichtes Manuskript)"},{"issue":"6","key":"5473_CR33","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/0378-5122(96)01038-9","volume":"24","author":"JR Hilditch","year":"1996","unstructured":"Hilditch JR, Lewis J, Peter A, van Maris B, Ross A, Franssen E, Guyatt GH, Norton PG, Dunn E (1996) A menopause-specific quality of life questionnaire: development and psychometric properties. Maturitas 24(6):161\u2013175","journal-title":"Maturitas"},{"key":"5473_CR34","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: a practical and powerful approach to multiple hypothesis testing. J R Stat Soc B 57:289\u2013300","journal-title":"J R Stat Soc B"},{"issue":"4","key":"5473_CR35","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1200\/JCO.2017.74.6651","volume":"36","author":"NL Henry","year":"2018","unstructured":"Henry NL, Unger JM, Schott AF, Fehrenbacher L, Flynn PJ, Prow DM, Sharer CW, Burton GV, Kuzma CS, Moseley A, Lew DL, Fisch MJ, Moinpour CM, Hershman DL, Wade JL III (2018) Randomized, multicenter, placebo-controlled clinical trial of duloxetine versus placebo for aromatase inhibitor-associated arthralgias in early-stage breast cancer: SWOG S1202. J Clin Oncol 36(4):326\u2013332","journal-title":"J Clin Oncol"},{"issue":"17","key":"5473_CR36","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1200\/JCO.2014.59.5595","volume":"33","author":"DL Hershman","year":"2015","unstructured":"Hershman DL, Unger JM, Crew KD, Awad D, Dakhil SR, Gralow J, Greenlee H, Lew DL, Minasian LM, Till C, Wade JL III, Meyskens FL, Moinpour CM (2015) Randomized multicenter placebo-controlled trial of omega-3 fatty acids for the control of aromatase inhibitor-induced musculoskeletal pain: SWOG S0927. J Clin Oncol 33(17):1910\u20131917","journal-title":"J Clin Oncol"},{"key":"5473_CR37","doi-asserted-by":"crossref","unstructured":"Hershman DL et al Randomized blinded sham- and waitlist-controlled trial of acupuncture for joint symptoms related to aromatase inhibitors in women with early stage breast cancer (SWOG 1200). Oral Presentation at: San Antonio Breast Cancer Symposium December 2017","DOI":"10.1158\/1538-7445.SABCS17-GS4-04"},{"issue":"6","key":"5473_CR38","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1097\/GME.0000000000000093","volume":"21","author":"G Huang","year":"2014","unstructured":"Huang G, Basaria S, Travison TG, Ho MH, Davda M, Mazer NA, Miciek R, Knapp PE, Zhang A, Collins L, Ursino M, Appleman E, Dzekov C, Stroh H, Ouellette M, Rundell T, Baby M, Bhatia NN, Khorram O, Friedman T, Storer TW, Bhasin S (2014) Testosterone dose-response relationships in hysterectomized women with or without oophorectomy: effects on sexual function, body composition, muscle performance and physical function in a randomized trial. Menopause 21(6):612\u2013623","journal-title":"Menopause"},{"issue":"4","key":"5473_CR39","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.maturitas.2010.12.001","volume":"68","author":"R Glaser","year":"2011","unstructured":"Glaser R, York AE, Dimitrakakis C (2011) Beneficial effects of testosterone therapy in women measured by the validated Menopause Rating Scale (MRS). Maturitas 68(4):355\u2013361","journal-title":"Maturitas"},{"issue":"Suppl 2","key":"5473_CR40","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1200\/jco.2014.32.26_suppl.109","volume":"32","author":"RL Glaser","year":"2014","unstructured":"Glaser RL, York AE, Dimitrakakis C (2014) Efficacy of subcutaneous testosterone on menopausal symptoms in breast cancer survivors. J Clin Oncol 32(Suppl 2):109","journal-title":"J Clin Oncol"},{"issue":"3","key":"5473_CR41","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1001\/jamaoncol.2016.3904","volume":"3","author":"ME Melisko","year":"2017","unstructured":"Melisko ME, Goldman ME, Hwang J, de Luca A, Fang S, Esserman LJ, Chien AJ, Park JW, Rugo HS (2017) Vaginal testosterone cream vs estradiol vaginal ring for vaginal dryness or decreased libido in women receiving aromatase inhibitors for early-stage breast cancer: a randomized clinical trial. JAMA Oncol 3(3):313\u2013319","journal-title":"JAMA Oncol"},{"issue":"11","key":"5473_CR42","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1097\/GME.0000000000001238","volume":"25","author":"F Labrie","year":"2018","unstructured":"Labrie F, Archer DF, Koltun W, Vachon A, Young D, Frenette L, Portman D, Montesino M, C\u00f4t\u00e9 I, Parent J, Lavoie L, BSc AB, Martel C, Vaillancourt M, Balser J, Moyneur \u00c9, members of the VVA Prasterone Research Group (2018) Efficacy of intravaginal dehydroepiandrosterone (DHEA) on moderate to severe dyspareunia and vaginal dryness, symptoms of vulvovaginal atrophy, and of the genitourinary syndrome of menopause. Menopause 25(11):1339\u20131353","journal-title":"Menopause"},{"issue":"4","key":"5473_CR43","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1007\/s00520-017-3960-9","volume":"26","author":"DL Barton","year":"2018","unstructured":"Barton DL, Shuster LT, Dockter T, Atherton PJ, Thielen J, Birrell SN, Sood R, Griffin P, Terstriep SA, Mattar B, Lafky JM, Loprinzi CL (2018) Systemic and local effects of vaginal dehydroepiandrosterone (DHEA): NCCTG N10C1 (Alliance). Support Care Cancer 26(4):1335\u20131343","journal-title":"Support Care Cancer"},{"issue":"2","key":"5473_CR44","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1152\/physiolgenomics.00085.2017","volume":"50","author":"JM Dempsey","year":"2018","unstructured":"Dempsey JM, Xi J, Henry NL, Rae JM, Hertz DL (2018) Attempted replication of SNPs in RANKL and OPG with musculoskeletal adverse events during aromatase inhibitor treatment for breast cancer. Physiol Genomics 50(2):98\u201399","journal-title":"Physiol Genomics"},{"issue":"8","key":"5473_CR45","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1517\/14740338.2015.1053458","volume":"14","author":"A Lintermans","year":"2015","unstructured":"Lintermans A, Neven P (2015) Safety of aromatase inhibitor therapy in breast cancer. Expert Opin Drug Saf 14(8):1201\u20131211","journal-title":"Expert Opin Drug Saf"},{"issue":"10","key":"5473_CR46","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1200\/JCO.2014.57.1547","volume":"33","author":"ML Irwin","year":"2015","unstructured":"Irwin ML, Cartmel B, Gross CP, Ercolano E, Li F, Yao X, Fiellin M, Capozza S, Rothbard M, Zhou Y, Harrigan M, Sanft T, Schmitz K, Neogi T, Hershman D, Ligibel J (2015) Randomized exercise trial of aromatase inhibitor-induced arthralgia in breast cancer survivors. J Clin Oncol 33(10):1104\u20131111","journal-title":"J Clin Oncol"},{"issue":"1","key":"5473_CR47","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s10549-018-4811-1","volume":"171","author":"CA Santa-Maria","year":"2018","unstructured":"Santa-Maria CA, Bardia A, Blackford AL, Snyder C, Connolly RM, Fetting JH, Hayes DF, Jeter SC, Miller RS, Nguyen A, Quinlan K, Rosner GL, Slater S, Storniolo AM, Wolff AC, Zorzi J, Henry NL, Stearns V (2018) A phase II study evaluating the efficacy of zoledronic acid in prevention of aromatase inhibitor-associated musculoskeletal symptoms: the ZAP trial. Breast Cancer Res Treat 171(1):121\u2013129","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"5473_CR48","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s10549-018-4946-0","volume":"172","author":"S Shen","year":"2018","unstructured":"Shen S, Unger JM, Crew KD, Till C, Greenlee H, Gralow J, Dakhil SR, Minasian LM, Wade JL III, Fisch MJ, Henry NL, Hershman DL (2018) Omega-3 fatty acid use for obese breast cancer patients with aromatase inhibitor-related arthralgia (SWOG S0927). Breast Cancer Res Treat 172(3):603\u2013610","journal-title":"Breast Cancer Res Treat"},{"issue":"13","key":"5473_CR49","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1001\/jama.2013.2813","volume":"309","author":"EM Smith","year":"2013","unstructured":"Smith EM et al (2013) Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial. JAMA 309(13):1359\u20131367","journal-title":"JAMA"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-020-05473-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-020-05473-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-020-05473-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T09:31:00Z","timestamp":1722850260000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-020-05473-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,6]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["5473"],"URL":"https:\/\/doi.org\/10.1007\/s00520-020-05473-2","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,6]]},"assertion":[{"value":"19 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The US NCI provided funding for this trial.The authors have no financial relationship with any private company regarding this research with the exception that Dr. Birrell reports personal fees from Havah Therapeutics, that is developing androgen-based therapies for women, and has a patent AU2005905768A0; additionally, Dr. Glaser has a patent (US 10,071,104 B2) related to this topic.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclaimer"}}]}}